Black Diamond Therapeutics, Inc. Common Stock
BDTX
BDTX: Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-189 and BDTX-1535.
moreShow BDTX Financials
Recent trades of BDTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BDTX's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Tyrosine kinase inhibitor compositions, methods of making and methods of use Jun. 15, 2021
Federal grants, loans, and purchases
Followers on BDTX's company Twitter account
Number of mentions of BDTX in WallStreetBets Daily Discussion
Recent insights relating to BDTX
Recent picks made for BDTX stock on CNBC
ETFs with the largest estimated holdings in BDTX
Flights by private jets registered to BDTX